ATAI Life Sciences Overview

  • Founded
  • 2018
Founded
  • Status
  • Public
  • Employees
  • 65
Employees
  • Stock Symbol
  • ATAI
Stock Symbol
  • Investments
  • 16
  • Share Price
  • $4.97
  • (As of Monday Closing)

ATAI Life Sciences General Information

Description

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine.

Contact Information

Website
www.atai.life
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • C/o Mindspace
  • Krausenstraße 9-10
  • 10117 Berlin
  • Germany
+49 089 00000000

ATAI Life Sciences Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ATAI Life Sciences Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.97 $5.12 $4.62 - $22.91 $821M 160M 1.14M -$1.16

ATAI Life Sciences Financials Summary

In Thousands,
USD 		TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 1,847,422
Revenue 20,146 0 0
EBITDA (179,324) (101,860) (17,491)
Net Income (165,525) (169,843) (14,138)
Total Assets 484,109 111,548 62,116
Total Debt 838 2,177 157
Public Fundamental Data provided by Morningstar, Inc. disclaimer

ATAI Life Sciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ATAI Life Sciences‘s full profile, request access.

Request a free trial

ATAI Life Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health d
Drug Discovery
Berlin, Germany
65 As of 2021
00000
0.000 0000-00-00
00000000 00000

000000 0

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariat
0000 000000000
Boston, MA
000 As of 0000
00000
00000000000 00000

0000 000

t dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut al
0000000000000
Cambridge, MA
000 As of 0000
00.000
000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ATAI Life Sciences Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Karuna Therapeutics Formerly VC-backed Boston, MA 000 00000 00000000000 00000
0000 000000000000 Formerly VC-backed Cambridge, MA 000 00.000 000000000 00.000
000000 00000000000 Corporation New York, NY 000 000.00 00000000 000.00
You’re viewing 3 of 3 competitors. Get the full list »

ATAI Life Sciences Executive Team (13)

Name Title Board Seat Contact Info
Florian Brand Chief Executive Officer & Founder
Srinivas Rao MD Chief Scientific Officer & Founder
Ryan Barrett JD General Counsel and Lead, Corporate Development
Aaron Weaver Senior General Counsel and Lead Investor Relations
Danny Talati Lead, Business Development
You’re viewing 5 of 13 executive team members. Get the full list »

ATAI Life Sciences Board Members (8)

Name Representing Role Since
Alexis de Rosnay ATAI Life Sciences Board Member 000 0000
Andrea Smiley ATAI Life Sciences Board Member 000 0000
Christian Angermayer Self Chairman of Supervisory Board & Board Member 000 0000
Gregory Weaver Self Chief Financial Officer & Board Member 000 0000
Jason Camm Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

ATAI Life Sciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ATAI Life Sciences Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ATAI Life Sciences‘s full profile, request access.

Request a free trial

ATAI Life Sciences Investments & Acquisitions (16)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000 09-Dec-2021 00000 0000 Drug Discovery 0000000 0
000000000 000 14-May-2021 0000 0000 Drug Delivery 0000000 0
000000 07-Apr-2021 0000000000 Therapeutic Devices 000000000
000000000 000 06-Nov-2020 0000000000 Biotechnology 00000000
Kures 09-Jul-2020 Merger/Acquisition Drug Discovery 0000000 0
You’re viewing 5 of 16 investments and acquisitions. Get the full list »

ATAI Life Sciences Subsidiaries (2)

Company Name Industry Location Founded
Kures Drug Discovery Dobbs Ferry, NY 2017
000000 Therapeutic Devices New York, NY
To view ATAI Life Sciences’s complete subsidiaries history, request access »

ATAI Life Sciences Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 00000000 17-Apr-2020 00000 00000 00 000.00 Completed
  • 17 buyers
0000000 00000000 20-Sep-2018 00000 00000 00 000.00 Completed
  • 5 buyers
COMPASS Pathways Later Stage VC 000.00 Completed
To view ATAI Life Sciences’s complete exits history, request access »